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1100-41 An Angiogrsphic Risk Score Integrating Both Epicardial 
and Tissue Level Perfusion Before and After Faci l i tated 
Percutaneous Coronary Intervention in Acute MI 
Michael Gibson, Sabina A. Murphy, Susan J. Marble, Staven P. Gourlay, Raymond 
Gibbons, Hal V. Barron, Harvard Clinical Research Institute, Boston, Massachusetts. 
Background: Both epicardial and tissue level parfuslon have been related to cliolcaJ out- 
comes in the setting of acute myocardial infarction (AMI), and the performance of adjunctive/ 
rescue parcutaneous intervention may alter clinical outcomes after thrombolytic administra- 
tion. Objectives & Methods: The goal of this study was to develop a simple, broadly appli- 
cable method that integrates epicardial and tissue level perfusion both before and after PCI 
to arrive at a single angiographic risk score (ARS) in patients undergoing PCI after thrembol- 
ysis. The anglographic risk score is the arithmetic sum of the TIMI Flow Grade (0-3) added to 
the TIMI Myocardial Perfusion Grade (0-3) before and after PCI (total possible score of 0- 
12). This risk score was evaluated in patients from the LIMIT AMI trial of tPA monotherapy vs 
tPA plus rhuMAb CD18. Infarct size was assessed using 120-216 hr post-AMI SPECT Tech- 
netium-99m Sestamibi data. Results: Those patients with an anglographic risk score in the 
lowest group (0-6) had a risk of 30 day death or MI of 9.3% (5/54), whereas those with an 
ARS of 7-12 had a risk of 1.3% (1/79)(p=0.04). There were no deaths or recurrent MIs 
among patients with a risk score greater than 10. Likewise, larger SPECT infarct sizes were 
observed among patients with an ARS of 0-6 (22.6% + 20.4%, n=53) compared to those 
patients with an ARS of 7-12 (12.3% + 14,3%, n=71, p--0.001). In a second analysis, data 
from patients who did not undergo PCI was incorporated by using the final TIMI Flow Grade 
and the final TIMJ Myocardial Peffusion Grade on diagnostic arteriography instead of the 
post PCI values, and similar results were seen: the risk of 30 day death or MI was 11.7% (11/ 
94) for ARS of 0-6, whereas it was 4.2% (6/143) for ARS of 7-12. SPECT infarct sizes were 
larger for ARS of 0-6 (21.0 + 19.0, n=84) vs ARS of 7-12 (11.8 + 15.2, n=127, p=0.0001). 
Conclusione: The angiographic risk score integrates indexes of epicardial and tissue level 
perfusion before and after PCI or at the end of diagnostic cardiac catheterization to arrive at 
a single risk estimate that is associated with infarct size and 30 day death or Ml. Failure to 
achieve an ARS of > 6 is associated with a doubling of infarct size. 
1100-42 Myocardial Perfusion in Pat ients  With Non-ST-Segment 
Elevation Acute Coronary Syndrome Assessed With 
Venous Contrast Echocardiography 
Christian Firschke, Marzenna Zlelinska, Stafan Martinoff, Peter Andrassy, Markus 
Schwaiger, Albert Sch6mig, Deutsches Herzzentrum, M(Jnchen, Germany. 
Non ST segment elevation acute coronary syndrome (NSTEACS) is a dynamic condition and 
the underlying pathophyslology is currently thought o comprise not only atherosderotic plaque 
rupture and supedml:x~=d thrombosis of an epicardial coronary artery but also microvasoular 
obstruction to flow due to vasoconstriction, microemboUsation a d adherence of activated blood 
cells to microvascular endothelium. We therefore sought to compare venous myocardial contrast 
echecardiography (VMCE), a new bedside technique allowing for exclusive imaging myocardial 
vascutsture, to Sestamibi SPECT (SI), angiographic and biochemical findings in patients with 
NSTEACS. 
60 patients (women, n=15, age 65-zlly) with typical anginal chest pain at rest or during minimal 
physiceJ activity plus either transient EKG changes (w~hout ST segment elevation) or elevated 
Troponin T (> 0.03 pg/ml) on presentation were included in the study. All patients underwent 
VMCE (3ml Optison in 27ml NaCI, 200m~, intermittent harmonic imaging every 5th endsystole, 
off-line digital image precessmg), SI and coronary angiography within 1 hour after presentation. 
52/60 patients (87%) had myocardial contrast defects on VMCE. Concordance with respect o 
presence of myocardial defects on SI was 88% (k=0.74). 26/60 patients (43%) had TIMI flow <3; 
all of these patients had a contrast defect on VMCE and 17/26 patients (65%) had elevated 
Troponin I. 34/60 patients (57%) had TIMI flow 3; 26/34 patients (76%) had a conf~'ast defect on 
VMCE and 14/34 patients (41%) had elevated Troponin I. 
We conclude that VMCE is a promising method for evaluation of myocardial parlusicn in patients 
with NSTEACS. It is reasonable to further invsetigate ~ role for diagnostic workup and follow up 
of patients with NSTEACS. 
1100-43 S ign i f icant  Myocardial Salvage in Patients With Non-ST 
Elevation Myocardial Infarction Is Common: Results 
Using Serial Myocardial Perfusion Imaging 
Michael C. Kontos. Karen A. Kurdzial, Joseph P. Ornato, Robert L. Jesse, James L. 
Tatum, MCV/VCU, Richmond, Virginia. 
Background: Technatium-99m sestamibi can delineate both myocardium at risk and final 
infarct size in patient (pts) with myocardial infarction (MI). Serial myocardial perfusion imag- 
ing (MPI) in pts with non-ST elevation MI has net been described previously. Methods: Pts 
with non-ST elevation MI who had MPI at the time of Emergency Department (ED) presen- 
tation were included. Percent defect size was quantitated using a 50% threshold derived 
from a phantom (r=0.99) using multiple short axis slices. Myocardial risk area was defined 
as the initial defect size; infarct area as the defect size on repeat MPI; and myocardial sal- 
vage as the difference between the two. Ejection fraction (EF) was calculated using a pre- 
viously validated computer algorithm (QGS). Results: There were 69 pts who had acute 
ED MPI and MI who underwent repeat MPI a median 5 days later. Revasculadzation was 
performed in 46 pts (67%) (only 2 within 12 hours of presentation). Variation in both mean 
peak CK (704±t223 U/L, median 377 U/L, range 91 to 9319 U/L) and risk area (19±10%, 
median 19%, range 2-46%) was high. Mean final infarct size, 11++9% (median 9%, range 
0-35%), was significantly smaller (p<0.001), and was only 57% of the initial dsk area. Sig- 
nificant salvage (initial risk area-final infarct size >25%) occurred in most pts (67%), with 
54% of pts having > 50% salvage. Pts with significant salvage had an increase in EF (48 to 
55%, 22% increase, p<0.01), while those without significant salvage EF decreased (49 to 
48%, 2% decrease, p=NS). Conclusions: The ischemic risk area in pts with non-ST eleva- 
tion MI can be large. Significant myocardial salvage is common, is not limited to those that 
have early revasculadzation, and is associated with improved EF. 
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1100-44 Old Age and Myocardial In farct  Size in the Reperfusion 
Era 
Robed A. Kloner. Ken Pools, Thomas Shook, Karin Przyktsnk, Kitty PerrJtt, Good 
Samaritan Hospital, Los Angeles, California, University of Southern California, Los 
Angeles, California. 
It is well established that cardiac death and complications are more common in elderly 
patients who suffer myocardial infarction. Although the mechanism for this increased 
morbidity and morality is unknown, one potential explanation, extrapolated from some 
experimental models of myocardial iscbomia/repeffusion, is that an age-associated 
increase in infarct size may play a role. Data on infract size in old versus young patients 
are lacking. We examined whether CK-MB determined myocardial infarct size differed in 
elderly (65 years or older) versus younger (< 65 years old) patients who did not have cor. 
onary reperfuslon (from the prethrcmbolytic era MILLS study) and from the more recent 
thrombolytic TIMI 4 trial. Infarct size data in MILLS (MB infarct size index = area under 
MB-CK curve adjusted for body surface area) was collected in 639 patients < 65 and 213 
elderly patients. Mean MB infarct size index was 15.59 _+ 0.59 Units for those < 65 and 
11.89 ± 033 Units for eldedy patients (p = 0.0003). Infarct size data in TIMI 4 (MB-CK = 
average MBoCK over first 14 hours) was collected in 260 patients < 65 and 140 elderly 
patients. Mean MB-CK infarct size was 123.2 ± 8.3 Intamational Units per liter (IU/L) in 
patients < 65 and 119.5 ± 10.4 IU/L for elderly patients (p = 0.78). The smaller infarcts in 
older MILLS patients were not due to lower presenting heart rates which were 793 boats/ 
rain (mean) in elderly patients and 80.4 for younger patients (p = NS); mean heart rates 
in TIMI 4 were 73.4 in elderly patient and 71.1 in younger patients (p = NS). These data 
suggest that in the absence of reperfusion, infract size is smaller (rather than larger) in 
older patients. Reperfusion changes this relationship reeufling in equally sized infarcts in 
old versus young, suggesting that in the reperfuslon era, infarct size is not larger in eld- 
erly patients and probably does not contribute to their worse outcome. 
1100-45 Rar i ty of  C i rcumf lex  Culpr i ts  in ST-Elevat ion MI is Due 
to Relative ECG Silence 
Thanh T. Nouven. Simon R. Dixon, John A. Fry, William W. O'Neill, Cindy L. Grines, 
James A. Goldstein, William Beaumont Hospital, Royal Oak, Michigan. 
Background: Angiographlo studies of ST-elevation myocardial infarction (MI) consis- 
tently document hat the left circumflex coronary artery (CFX) is uncommonly the culprit 
vessel compared to the left anterior descending (LAD) and the right coronary (RCA). 
Since there is no a priori reason to expect a differential propensity of the three coronary 
vessels to acute plaque instability, we hypothesized that this disparity of CFX culprits 
may result from ECG insensitivity in detection of lateral wall transmural ischemia. If this 
hypothesis is correct, the distribution of culprit vessels in non ST-elevation acute coro- 
nary syndromes(ACS) would be expected to be relatively even. Methods: We retrospec- 
tively analyzed angiograms from our cath lab database to identify the culprit vessel in 
166 pts with ST-elevation MI and in 134 others with non-ST elevation ACS. Results: In 
pts with ST-elevation MI, the CFX was uncommonly the culpdt vessel (12%), compared 
to LAD (43%) or RCA (45%) involvement (CFX vs LAD or RCA, p<0.001), However, in 
pts with non-ST elevation ACS, the distdbution of culprit vessels was more even and in 
fact the CFX was most frequently the culprit vessel (40%), whereas the LAD was respon- 
sible in 28% of pts and the RCA in 32% of cases (CFX vs LAD or RCA, p=NS). Com- 
pared to pts with ST-elevation, in those with non-ST elevation ACS the CFX was more 
commonly the culprit vessel (40 vs 12%, p<0.001). The frequency of LAD and RCA cul- 
prits was similar between the two groups. Conclusions: These findings document a 
striking disparity in the prevalence of CFX culprits in pts with ST-eiavation MI compared 
to non-ST eiavatlon ACS. The rarity of CFX culprits in ST-alevation MI but even distribu- 
tion in other ACS, suggests that the CFX is just as likely to develop plaque rupture but 
that lateral wall transmural ischemia is often missed by ECG. 
1100-46 Does Prior Angina Predict Outcomes Following Acute 
Myocardial Infarction? Testing the Relevance of 
Ischemic Pre-Condi t ion ing in the Era of Pr imary  
Angioplasty 
Kishore J. Harjai, Cindv L. Grines. H. Mehrdad Sadeghi, Calvin Ledford, Dominic 
Marsalese, Judith Boura, Robert D. Safian, James A. Goldstein, Joel Kahn, William W. 
O'Neill, Primary Angiopiasty in Myocardial Infarction (PAMI) Group, William Beaumont 
Hospital, Royal Oak, Michigan. 
Background: In animal studies, brief periods of myocardial ischemia reduce the size of 
the infarct resulting from a subsequent total occlusion. It is postulated that angina pre- 
ceding acute myocardial infarction (AMI) may provide similar benefit in humans. How- 
ever, clinical studies on the prognostic impact of preinfarction angina have shown mixed 
results. 
Methods: We tested the effect of prior angina on in-hospital outcomes [ischemic target 
vessel revascularization (TVR), reinfarotion, death, & MACE (combined end-point)] in the 
pooled database of 2558 patients enrolled in Primary Angioplasty in Myocardial Infarction 
(PAMI)-2 &Stent PAMI trials. To minimize confounding from silent ischemia & atharoscle- 
rotic burden, we excluded 878 (34%) patients with a history of diabetes, pdor myocardial 
infarction, prior percutaneous coronary intervention or coronary artery bypass surgery 
from this analysis, In the remaining 1680 patients, we compared angiogrephic & clinical 
outcomes between patients with (n=230, 17%) & those without prior angina (n=1450, 
83%). 
Results: Prior angina patients had a higher incidence of hypertension (50 vs 40%), dys- 
lipidemia (45 vs 33%), peripheral vascular disease (5.7 vs 3.0%), & previous aspirin use 
(24 vs 9%, p<O.05 for all). The 2 groups had otherwise similar baseline clinical & anglo- 
graphic features. Stent use (29 vs 29%), final TIMI-3 flow (91 vs 92%), mean residual 
stenosis (22 vs 21%), & cath lab complications (33 vs 29%) were comparable between 
groups. Patients with prior angina had similar incidence of in-hospital reinfarotion (1.3 vs 
